Use of a chronic model of articular cartilage and meniscal injury for the assessment of long-term effects after autologous mesenchymal stromal cell treatment in sheep

•Translational large animal model, relevant to the clinical condition in humans.•Long-term end-points for the assessment of efficacy and safety.•Evidence of improvement macroscopic and histological parameters that measure cartilage quality after injection of expanded mesenchymal stromal cells. Regen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New biotechnology 2014-09, Vol.31 (5), p.492-498
Hauptverfasser: Caminal, Marta, Fonseca, Carla, Peris, David, Moll, Xavier, Rabanal, Rosa M., Barrachina, Josep, Codina, David, García, Félix, Cairó, Jordi J., Gòdia, Francesc, Pla, Arnau, Vives, Joaquim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Translational large animal model, relevant to the clinical condition in humans.•Long-term end-points for the assessment of efficacy and safety.•Evidence of improvement macroscopic and histological parameters that measure cartilage quality after injection of expanded mesenchymal stromal cells. Regenerative therapies using adult stem cells have attracted great interest in the recent years and offer a promising alternative to current surgical practices. In this report, we evaluated the safety and efficacy of an autologous cell-based treatment of osteoarthritis using mesenchymal stromal cells expanded from bone marrow aspirates that were administered intra-articularly. Ten 2-year old ewes were divided in two groups (for analysis at 6 and 12 months, respectively). Full thickness articular cartilage defects of approximately 60mm2 were created arthroscopically in the medial femorotibial condyles and a meniscal tear in the anterior horn of the medial meniscus in the 20 hind legs. Intra-articular injection of 4mL of either treatment (a suspension of cells) or control (same as treatment, without cells) were applied one month after generating a chronic condition similar to human pathology. Animals were monitored radiographically, by MRI and ultrasound scanning; and macroscopic and histological analyses were conducted at 6 and 12 months. Furthermore a full necropsy was performed at 12 months post-treatment. The intra-articular injection of autologous MSC was safe, as judged by the lack of local or systemic adverse effects during the clinical follow-up and by a full necropsy performed at 12 months post-treatment. Evidence of regeneration of articular cartilage and meniscus was case-dependent but statistically significant improvement was found in specific macroscopic and histological parameters. Such parameters included colour, rigidity, cell distribution and hyaline quality of the refill tissue as well as the structure of subchondral bone.
ISSN:1871-6784
1876-4347
DOI:10.1016/j.nbt.2014.07.004